10.28.26 -- When Lyophilization Fails At Scale, First Scrutinize Your Formulation

Unlock innovation in biotherapeutics with expert insights into DSC and molecular stability. Learn how biophysical techniques can optimize formulations and enhance nucleic acid stability.

In sterile development, the decisions with the greatest downstream consequences are rarely recognized as such when they are made. Examine how these choices shape program outcomes across the lifecycle.

Uncover how advanced tubing materials improve weld integrity, reduce particulates, and support sterilization compatibility for closed-system bioprocessing.

Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.

Explore the growing demand for high‑concentration biologics, and the formulation, viscosity, and manufacturing challenges driving new technologies for stable, scalable drug development.

Active HEPA filtration protects cell cultures by restoring air quality within minutes. Find out how continuous purification reduces contamination risks and ensures reliable, reproducible research.

Thoughtful design at the bioreactor and ATF interface can reduce shear, simplify fluid paths, and conserve space. See how rethinking an overlooked valve assembly helped improve process efficiency.

Gain insight into how single-pass tangential flow approaches improve efficiency, scalability, and product quality while addressing key development and processing challenges.

As upstream processes intensify, chromatography polishing must handle higher loads and evolving impurity profiles. Modern strategies can improve clearance, extend resin life, and maintain throughput.

Rising complexity in ADCs and biologics makes sterile manufacturing more critical than ever. Discover approaches to outsourcing, lyophilization, and quality management that support success.